Processes for the preparation of o-(6-pyrazol-1-yl-pyridin-3-ylmethyl)-hydroxylamine
    1.
    发明授权
    Processes for the preparation of o-(6-pyrazol-1-yl-pyridin-3-ylmethyl)-hydroxylamine 有权
    制备邻 - (6-吡唑-1-基 - 吡啶-3-基甲基) - 羟胺的方法

    公开(公告)号:US07538225B2

    公开(公告)日:2009-05-26

    申请号:US11205764

    申请日:2005-08-17

    IPC分类号: C07D401/04

    CPC分类号: C07D401/04 C07D401/14

    摘要: The present invention relates generally to novel methods for the synthesis of O-(6-pyrazol-1-yl-pyridin-3-ylmethyl)-hydroxylamine which is an essential reagent in the synthesis of one of the bridged erythromycin derivatives and their respective pharmaceutically acceptable salts in PCT Application WO 03/097659 A1. In particular, the present invention relates to processes and intermediates for the preparation of a compound of formula (Ia):

    摘要翻译: 本发明一般涉及合成O-(6-吡唑-1-基 - 吡啶-3-基甲基) - 羟胺的新方法,其是合成桥联红霉素衍生物之一及其各自药学上的必需试剂 PCT申请WO 03/097659 A1中的可接受的盐。 特别地,本发明涉及制备式(Ia)化合物的方法和中间体:

    PROCESSES FOR THE PREPARATION OF HYDROXYLAMINES
    2.
    发明申请
    PROCESSES FOR THE PREPARATION OF HYDROXYLAMINES 失效
    制备羟甲基胺的方法

    公开(公告)号:US20080242865A1

    公开(公告)日:2008-10-02

    申请号:US12135299

    申请日:2008-06-09

    IPC分类号: C07D401/04

    CPC分类号: C07D401/04 C07D401/14

    摘要: The present invention relates generally to novel methods for the synthesis of O-(6-pyrazol-1-yl-pyridin-3-ylmethyl)-hydroxylamine which is an essential reagent in the synthesis of one of the bridged erythromycin derivatives and their respective pharmaceutically acceptable salts in PCT Application WO 03/097659 A1. In particular, the present invention relates to processes and intermediates for the preparation of a compound of formula (Ia):

    摘要翻译: 本发明一般涉及合成O-(6-吡唑-1-基 - 吡啶-3-基甲基) - 羟胺的新方法,其是合成桥联红霉素衍生物之一及其各自药学上的必需试剂 PCT申请WO 03/097659 A1中的可接受的盐。 特别地,本发明涉及制备式(Ia)化合物的方法和中间体:

    Processes for the preparation of hydroxylamines
    3.
    发明授权
    Processes for the preparation of hydroxylamines 失效
    制备羟胺的方法

    公开(公告)号:US07919627B2

    公开(公告)日:2011-04-05

    申请号:US12135299

    申请日:2008-06-09

    IPC分类号: C07D401/04

    CPC分类号: C07D401/04 C07D401/14

    摘要: The present invention relates generally to novel methods for the synthesis of O-(6-pyrazol-1-yl-pyridin-3-ylmethyl)-hydroxylamine which is an essential reagent in the synthesis of one of the bridged erythromycin derivatives and their respective pharmaceutically acceptable salts in PCT Application WO 03/097659 A1. In particular, the present invention relates to processes and intermediates for the preparation of a compound of formula (Ia):

    摘要翻译: 本发明一般涉及合成O-(6-吡唑-1-基 - 吡啶-3-基甲基) - 羟胺的新方法,其是合成桥联红霉素衍生物之一及其各自药学上的必需试剂 PCT申请WO 03/097659 A1中的可接受的盐。 特别地,本发明涉及制备式(Ia)化合物的方法和中间体:

    Processes for the preparation of O-(6-pyrazol-1-yl-pyridin-3-ylmethyl)-hydroxylamine
    4.
    发明申请
    Processes for the preparation of O-(6-pyrazol-1-yl-pyridin-3-ylmethyl)-hydroxylamine 有权
    用于制备O-(6-吡唑-1-基 - 吡啶-3-基甲基) - 羟胺的方法

    公开(公告)号:US20060247440A1

    公开(公告)日:2006-11-02

    申请号:US11205764

    申请日:2005-08-17

    IPC分类号: C07D403/04 C07D401/00

    CPC分类号: C07D401/04 C07D401/14

    摘要: The present invention relates generally to novel methods for the synthesis of O-(6-pyrazol-1-yl-pyridin-3-ylmethyl)-hydroxylamine which is an essential reagent in the synthesis of one of the bridged erythromycin derivatives and their respective pharmaceutically acceptable salts in PCT Application WO 03/097659 A1. In particular, the present invention relates to processes and intermediates for the preparation of a compound of formula (Ia):

    摘要翻译: 本发明一般涉及合成O-(6-吡唑-1-基 - 吡啶-3-基甲基) - 羟胺的新方法,其是合成桥联红霉素衍生物之一及其各自药学上的必需试剂 PCT申请WO 03/097659 A1中的可接受的盐。 特别地,本发明涉及制备式(Ia)化合物的方法和中间体:

    6,11-bridged biaryl macrolides
    10.
    发明授权
    6,11-bridged biaryl macrolides 有权
    6,11桥接的联芳基大环内酯类

    公开(公告)号:US08354383B2

    公开(公告)日:2013-01-15

    申请号:US12399801

    申请日:2009-03-06

    IPC分类号: A61K31/70 C07H17/08

    摘要: The present invention discloses compounds of formula I, II or X, or pharmaceutically acceptable salts, esters, or prodrugs thereof: which exhibit antibacterial properties. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject in need of antibiotic treatment. The invention also relates to methods of treating a bacterial infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention. The invention further includes process by which to make the compounds of the present invention.

    摘要翻译: 本发明公开了式I,II或X的化合物或其药学上可接受的盐,酯或前药:其表现出抗菌性质。 本发明还涉及包含上述化合物的药物组合物,用于给予需要抗生素治疗的受试者。 本发明还涉及通过施用包含本发明化合物的药物组合物来治疗受试者的细菌感染的方法。 本发明还包括制备本发明化合物的方法。